Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of 18.59 is in line with its 5-year average of 17.22, near the high end of its 5-year range (15.53–19.61).
As of the fiscal period ended Wednesday, December 31, 2025. 8.24% above its 12-month average of 17.17.
Reported quarterly EPS; no daily interpolation.
EPS growth vs the same quarter one year earlier, last 40 quarters.
EARNINGS PER SHARE (EPS)
18.59
EARNINGS PER SHARE (EPS) AVG TTM
17.17
EARNINGS PER SHARE (EPS) AVG 3Y
16.90
EARNINGS PER SHARE (EPS) AVG 5Y
17.22
EARNINGS PER SHARE (EPS) AVG 10Y
12.33
EARNINGS PER SHARE (EPS) AVG 15Y
9.57
EARNINGS PER SHARE (EPS) AVG 20Y
7.70
CURRENT VS TTM AVG
+8.24%
CURRENT VS 3Y AVG
+9.98%
CURRENT VS 5Y AVG
+7.96%
CURRENT VS 10Y AVG
+50.81%
CURRENT VS 15Y AVG
+94.18%
CURRENT VS 20Y AVG
+141.53%
Thermo Fisher Scientific Inc.
Market Cap
$213.42B
Earnings Per Share (EPS)
18.59
TTM Avg
17.17
3Y Avg
16.90
5Y Avg
17.22
Market Cap
$209.19B
Earnings Per Share (EPS)
4.27
TTM Avg
3.38
3Y Avg
2.82
5Y Avg
2.39
Market Cap
$207.87B
Earnings Per Share (EPS)
14.37
TTM Avg
10.97
3Y Avg
11.67
5Y Avg
11.57
Market Cap
$184.11B
Earnings Per Share (EPS)
3.11
TTM Avg
5.71
3Y Avg
4.66
5Y Avg
4.19
Market Cap
$161.66B
Earnings Per Share (EPS)
7.34
TTM Avg
3.61
3Y Avg
3.85
5Y Avg
3.41
Market Cap
$137.13B
Earnings Per Share (EPS)
5.63
TTM Avg
5.20
3Y Avg
6.66
5Y Avg
6.73
Market Cap
$133.37B
Earnings Per Share (EPS)
4.54
TTM Avg
-0.48
3Y Avg
1.47
5Y Avg
0.84
Market Cap
$133.25B
Earnings Per Share (EPS)
2.27
TTM Avg
2.53
3Y Avg
3.71
5Y Avg
4.39
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Thermo Fisher Scientific Inc. (TMO) | $213.42B | 18.59 | 17.17 | 16.90 | 17.22 |
| Novo Nordisk A/S (NVO)vs › | $209.19B | 4.27 | 3.38 | 2.82 | 2.39 |
| Amgen Inc. (AMGN)vs › | $207.87B | 14.37 | 10.97 | 11.67 | 11.57 |
| Abbott Laboratories (ABT)vs › | $184.11B | 3.11 | 5.71 | 4.66 | 4.19 |
| Gilead Sciences, Inc. (GILD)vs › | $161.66B | 7.34 | 3.61 | 3.85 | 3.41 |
| Pfizer Inc. (PFE)vs › | $142.54B | 1.31 | 1.39 | 2.19 | 2.39 |
| Danaher Corporation (DHR)vs › | $137.13B | 5.63 | 5.20 | 6.66 | 6.73 |
| Bristol-Myers Squibb Company (BMY)vs › | $133.37B | 4.54 | -0.48 | 1.47 | 0.84 |
| CVS Health Corp. (CVS)vs › | $133.25B | 2.27 | 2.53 | 3.71 | 4.39 |
| AstraZeneca PLC (AZN)vs › | $131.47B | 13.28 | 11.14 | 8.54 | 6.53 |
Trailing EPS (TTM)
$18.59
Forward EPS (Est.)
$25.08
P/E Ratio
30.9
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | 17.77 |
| 2024-12-31 | 16.58 |
| 2023-12-31 | 15.53 |
| 2022-12-31 | 17.73 |
| 2021-12-31 | 19.61 |
| 2020-12-31 | 16.10 |
| 2019-12-31 | 9.24 |
| 2018-12-31 | 7.31 |
| 2017-12-31 | 5.64 |
| 2016-12-31 | 5.12 |
| 2015-12-31 | 4.96 |
| 2014-12-31 | 4.76 |
| 2013-12-31 | 3.53 |
| 2012-12-31 | 3.24 |
| 2011-12-31 | 3.49 |
| 2010-12-31 | 2.57 |
| 2009-12-31 | 2.06 |
| 2008-12-31 | 2.34 |
| 2007-12-31 | 1.81 |
| 2006-12-31 | 0.86 |
| 2005-12-31 | 1.38 |
| 2004-12-31 | 2.22 |
| 2003-12-31 | 1.23 |
| 2002-12-31 | 1.84 |
| 2001-12-31 | 0.00 |
| 2000-12-31 | -0.22 |
| 1999-12-31 | -1.11 |
| 1998-12-31 | 1.12 |
| 1997-12-31 | 1.57 |
| 1996-12-31 | 1.35 |
